Functionally, ephrin-B1 modulates multiple pathways, including p38, MSK1/2, Stat1/2/4/5a/6, and paxillin, following ligand stimulation or EphB2 inhibition, suggesting broad influence over tumor behavior (Sikkema et al., 2012). The gene discussed is PXN; the disease is neoplasm.